{
    "eid": "2-s2.0-85079848582",
    "title": "Emergence of novel coronavirus 2019-nCoV: Need for rapid vaccine and biologics development",
    "cover-date": "2020-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Molecular Biology",
            "@code": "1312",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Immunology and Microbiology (all)",
            "@code": "2400",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Microbiology (medical)",
            "@code": "2726",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Biopharmaceuticals",
        "Coronavirus",
        "Emerging threat",
        "Infectious diseases",
        "Plant system",
        "Transient expression",
        "Viruses",
        "Zoonoses"
    ],
    "authors": [
        "Balamurugan Shanmugaraj",
        "Ashwini Malla",
        "Waranyoo Phoolcharoen"
    ],
    "citedby-count": 102,
    "ref-count": 64,
    "ref-list": [
        "Infectious disease threats in the twenty-first century: Strengthening the global response",
        "Clinical features of patients infected with 2019 novel coronavirus in wuhan, China",
        "Genomic characterization and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding",
        "Coronavirus pathogenesis",
        "Structure, Function, and evolution of coronavirus spike proteins",
        "Origin and evolution of pathogenic coronaviruses",
        "Development of one-step, real-time, quantitative reverse transcriptase PCR assays for absolute quantitation of human coronaviruses OC43 and 229E",
        "A novel Coronavirus from patients with pneumonia in China, 2019",
        "A familial cluster of Pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster",
        "A major outbreak of severe acute respiratory syndrome in Hong Kong. New. Engl",
        "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study",
        "Plant expression platform for the production of recombinant pharmaceutical proteins",
        "Plant-made pharmaceuticals: Leading products and production platforms",
        "Plant-produced anti-Enterovirus 71 (EV71) monoclonal antibody efficiently protects mice against EV71 infection",
        "Cold chain and virus-free oral polio booster vaccine made in lettuce chloroplasts confers protection against all three poliovirus serotypes",
        "Production and immunogenicity of soluble plant-produced HIV-1 subtype C envelope gp140 immunogens",
        "Taliglucerase alfa: An enzyme replacement therapy using plant cell expression technology",
        "Molecular Pharming for low and middle income countries",
        "Plant-based vaccines against viruses",
        "Plant-made oral vaccines against human infectious diseases-Are we there yet?",
        "Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents",
        "A perspective on the development of plant-made vaccines in the fight against Ebola virus",
        "Expression and functional evaluation of biopharmaceuticals made in plant chloroplasts",
        "Development of systems for the production of plant-derived biopharmaceuticals",
        "Antibody responses in mice stimulated by various doses of the potato-derived major surface antigen of hepatitis B virus",
        "Freeze-drying of plant tissue containing HBV surface antigen for the oral vaccine against hepatitis B",
        "Supercritical fluid extraction provides an enhancement to the immune response for orally-delivered hepatitis B surface antigen",
        "Immunogenicity of chloroplast-derived HIV-1 p24 and a p24-Nef fusion protein following subcutaneous and oral administration in mice",
        "A chloroplast-derived C4V3 polypeptide from the human immunodeficiency virus (HIV) is orally immunogenic in mice",
        "A plant-derived Multi-HIV antigen induces broad immune responses in orally immunized mice",
        "Immunogenic properties of a lettuce-derived C4(V3)6 multiepitopic HIV protein",
        "Oral delivery of plant-derived HIV-1 p24 antigen in low doses shows a superior priming effect in mice compared to high doses",
        "Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice",
        "Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model",
        "Expression of H3N2 nucleoprotein in maize seeds and immunogenicity in mice",
        "Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein",
        "Expression of rabies glycoprotein and ricin toxin B chain (RGP-RTB) fusion protein in tomato hairy roots: A step towards oral vaccination for rabies",
        "Cold chain and virus-free chloroplast-made booster vaccine to confer immunity against different poliovirus serotypes",
        "Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine",
        "Expression of an immunogenic Ebola immune complex in Nicotiana Benthamiana",
        "Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity",
        "Characterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco",
        "Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants",
        "Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody",
        "Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans",
        "Enhanced transport of plant-produced rabies single-chain antibody-RVG peptide fusion protein across an in cellulo blood-brain barrier device",
        "A Broad and potent H1-specific human monoclonal antibody produced in plants prevents Influenza virus infection and transmission in Guinea Pigs",
        "Rapid transient production of a monoclonal antibody neutralizing the Porcine Epidemic Diarrhea Virus (PEDV) in Nicotiana benthamiana and Lactuca sativa",
        "In vitro and in vivo efficacy of anti-chikungunya virus monoclonal antibodies produced in wild-type and glycoengineered Nicotiana benthamiana plants",
        "Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants",
        "Commercialization of new biotechnology: A systematic review of 16 commercial case studies in a novel manufacturing sector",
        "Plant-made pharmaceuticals: FromEdible Vaccines to Ebola therapeutics",
        "From SARS to MERS, Thrusting Coronaviruses into the Spotlight",
        "Severe acute respiratory syndrome",
        "Structure of SARS coronavirus spike receptor-binding domain complexed with receptor",
        "Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus",
        "Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS",
        "Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: Target, mechanism of action, and therapeutic potential",
        "Antibodies and vaccines against Middle East respiratory syndrome coronavirus",
        "Recent Advances in the vaccine development against Middle East Respiratory Syndrome-Coronavirus"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Second Century Fund",
        "Chulalongkorn University"
    ]
}